How we use stem cells in research

reNEW will use stem cells to model human diseases, regenerate tissue and create gene-edited cells that can improve our ability to diagnose, treat and even prevent human disease. Such transformative stem cell medicines offer patients hope for a variety of incurable diseases such as chronic kidney disease, diabetes, heart failure, Parkinson’s, and muscular dystrophy. Read more on the reNEW Melbourne research projects.

reNEW research is anchored in three pillars – each will use stem cells differently.

  • reSOLVE – aims to create models of different diseases from patient-derived stem cells, and use these models to improve drug development.
  • reBUILD - aims to develop advanced cellular therapies and engineered tissues from patient-derived stem cells.
  • reWRITE – aims to develop new approaches to edit the genetic information within cells.

As a foundation to our lab-based research, our PREPARE pillar will focus on the ethical, social, regulatory and economic barriers of such groundbreaking advanced therapies and will work alongside the stem cell biologists to prepare for success.

Proudly in partnership with

The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729​​